Epidemiologist Erin Bowles, MPH, is looking at cancer screening and treatment from many different perspectives. Her research brings new insight into cancer risk factors, diagnosis, treatment, and survivorship, while helping improve cancer care for patients and families.
Erin received an R50 mid-career research award from the National Cancer Institute (NCI). This award is given to cancer researchers who have demonstrated successes and contributions to cancer research as a non-principal investigator. As a key member of 2 large cancer collaborations — the NCI's Breast Cancer Surveillance Consortium and the Health Care Systems Cancer Research Network (CRN) — Erin has developed diverse expertise that includes reading mammograms for breast density and using administrative data to understand patterns of care in cancer treatment.
Her current work includes:
Erin’s experience working with large observational cohorts and collaborations with numerous study teams over the past 20 years has provided her with expertise in data collection and quality control for many subject areas. She is also a manager of the Collaborative Science Division at KPWHRI, providing leadership, supervision, mentorship, and support to junior faculty.
Breast cancer; colorectal cancer; multiple myeloma; thyroid cancer; pancreatic cancer; biostatistics; epidemiology; mammography; mammographic breast density; cancer treatment; cancer screening and surveillance; automated data collection; quality of care; medication use; care coordination; administrative data
Access to care; health disparities; health outcomes research; quality of life; measurement of change in health care systems; practice variation
Menopause; hormone replacement therapy (HRT); breast cancer
Cognitive health and dementia; biostatistics; epidemiology; medication use; cancer
Pharmacoepidemiology; observational study research methods; chemotherapy; radiation exposure
Newton KM, Anderson ML, Reed SD, Bowles EJ, Buist DS. Factors associated with non-compliance with hormone therapy cessation before screening mammography. Climacteric. 2011 Apr;14(2):268-74. Epub 2010 Oct 27. PubMed
Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJ, Newton KM, Lampe JW. Sources of cadmium exposure among healthy premenopausal women. Sci Total Environ. 2011;409(9):1632-7. Epub 2011 Feb 17. PubMed
Carney PA, Aiello Bowles EJ, Sickles EA, Geller BM, Feig SA, Jackson S, Brown D, Cook A, Yankaskas BC, Miglioretti DL, Elmore JG. Using a tailored web-based intervention to set goals to reduce unnecessary recall. Acad Radiol. 2011 Apr;18(4):495-503. Epub 2011 Jan 20. PubMed
Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJ, Newton KM, Lampe JW. Urinary cadmium and mammographic density in premenopausal women. Breast Cancer Res Treat. 2011 Aug;128(3):837-44. Epub 2011 Feb 15. PubMed
Sprague BL, Trentham-Dietz A, Gangnon RE, Buist DS, Burnside ES, Aiello Bowles EJ, Stanczyk FZ, Sisney GS. Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer. 2011;2(1):62-72. PubMed
Carney PA, Geller BM, Sickles EA, Miglioretti DL, Aiello Bowles EJ, Abraham L, Feig SA, Brown D, Cook AJ, Yankaskas BC, Elmore JG. Feasibility and satisfaction with a tailored web-based audit intervention for recalibrating radiologists' thresholds for conducting additional work-up. Acad Radiol. 2011 Mar;18(3):369-76. Epub 2010 Dec 30. PubMed
The division contributes to research across the institute with methodological and subject matter expertise.
Kaiser Permanente Washington has been part of the national Breast Cancer Surveillance Consortium since 1994. Learn about the Kaiser Permanente Washington Breast Cancer Surveillance Registry here.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Cell by cell, scientists are building a high-resolution map of brain changes in Alzheimer’s disease.
Study suggests disparities at screening sites may influence lag in follow-ups.